Not only do IP CloseUp readers benefit from its weekly’s news and perspective, the weekly continues to provide attractive discounts to leading IP events and
China may not yet be on an equal footing with the leading industrialized nations in terms invention quality and brand recognition, but according to a
The birthplace of innovation, Boston, is the site for the 2018 Licensing Executives Society meeting. The opening session, “Advancing Innovation Through a Renewal of Trust,”
Responsible IP deal-making – where parties enter into licensing and other agreements mutually – has become something of a lost art. Not long ago, it
Qualcomm is the first known patent licensor to tout its invention prowess in a New York Times ad directed at the business community. One of the
Can Internet monopolies – adept at providing at providing information – be prevented from violating the rights of individuals, businesses and IP holders, and impeding innovation?
One of America’s most successful and charitable patent licensing strategists passed away last week. Eugene M. Lang, describe as “an American folk hero” for his
Not all patent owners agree the Patent Trial and Appeal Board (PTAB) is a fairer forum for vetting patent quality today. While some believe that
One of the leading public IP licensing companies, or PIPCOs, Tessera Holding Corporation, has changed its name to Xperi Corporation, an indication that it has
It was the second record-breaking year in a row for IP CloseUp readership, with 43,946 visits in 2016, an 81% increase from 24,273 in 2015.
Donald J. Trump, Jr.’s editorial in the The Daily Caller in 2012, a conservative leaning publication that generates more than 16 million monthly visits, indicates that
A unique public-private partnership provides medical research centers and the patents they generate with a more efficient and rewarding path toward commercialization. Bridge Medicines is a drug discovery